Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1185 | Obesity | ICEECE2012

Efficacy of orlistat vs placebo in the improvement of lipid profile among overweight and obese patients: a meta-analysis

Malong C. , Delgado J. , Cunanan E.

Background: According to the 6th National Nutrition Health Survey, the Filipino is generally unfit, with increasing incidences of major risk factors for cardiovascular disease like hypertension, abnormal lipid profile, obesity and diabetes over the last 5 years. Orlistat, a lipase inhibitor is one of the medications used to facilitate weight loss in obese patients. Given that weight loss is known to be associated with an improvement in the serum lipid profile, concurrent impro...